trans-[PdCl2(1-(3-hydroxypropyl)pyrazole)2] | 680183-60-2

• 英文名称: trans-[PdCl2(1-(3-hydroxypropyl)pyrazole)2]
• CAS: 680183-60-2
• 化学式: C₁₂H₂₀Cl₂N₄O₂Pd
• 分子量: 429.642
• InChiKey: BMNQLZMHQKZXQN-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为反应物：
  描述：

  3-(1-吡唑基)-1-丙醇 、 trans-[PdCl2(1-(3-hydroxypropyl)pyrazole)2] 、 silver tetrafluoroborate 以 not given 为溶剂， 生成 [Pd(1-(3-hydroxypropyl)pyrazole)4](BF4)2
  参考文献：
  名称：

  Synthesis and characterisation of pyrazolic palladium compounds containing alcohol functionality:

  摘要：

  The ligands 1-hydroxymethylpyrazole (hl(1)), 1-(2-hydroxyethyl)pyrazole (hl(2)) and 1-(3-hydroxypropyl)pyrazole (hl(3)) react with [PdCl2(CH3CN)(2)] to give trans-[PdCl2(hl)(2)] compounds. Due to a hindered rotation around the Pd-bond, these compounds present two different conformations in solution: anti and syn. The conformation presented depends on the relative disposition of the hydroxyalkylic chains of the two pyrazolic ligands. The present study was carried out on the basis of NMR experiments. The present paper reports the crystal structure of trans-[PdCl2(hl(2))(2)]. The synthesis and characterisation of compounds [Pd(hl)(4)](BF4)(2) (hl = hl(1), hl(2) and hl(3)) starting from [Pd(CH3CN)(4)](BF4)(2) and the corresponding chlorocomplexes trans-[PdCl2(hl)(2)] are also described. (C) 2003 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.ica.2003.06.015
• 作为产物：
  描述：

  双(乙腈)氯化钯(II) 、 3-(1-吡唑基)-1-丙醇 以 二氯甲烷 为溶剂， 以78%的产率得到trans-[PdCl2(1-(3-hydroxypropyl)pyrazole)2]
  参考文献：
  名称：

  Synthesis and characterisation of pyrazolic palladium compounds containing alcohol functionality:

  摘要：

  The ligands 1-hydroxymethylpyrazole (hl(1)), 1-(2-hydroxyethyl)pyrazole (hl(2)) and 1-(3-hydroxypropyl)pyrazole (hl(3)) react with [PdCl2(CH3CN)(2)] to give trans-[PdCl2(hl)(2)] compounds. Due to a hindered rotation around the Pd-bond, these compounds present two different conformations in solution: anti and syn. The conformation presented depends on the relative disposition of the hydroxyalkylic chains of the two pyrazolic ligands. The present study was carried out on the basis of NMR experiments. The present paper reports the crystal structure of trans-[PdCl2(hl(2))(2)]. The synthesis and characterisation of compounds [Pd(hl)(4)](BF4)(2) (hl = hl(1), hl(2) and hl(3)) starting from [Pd(CH3CN)(4)](BF4)(2) and the corresponding chlorocomplexes trans-[PdCl2(hl)(2)] are also described. (C) 2003 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.ica.2003.06.015